Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_assertion description "[clinical data suggesting that there could be a subpopulation of metastatic colorectal cancer patients that are more liable to benefit from anti-EGFR monoclonal antibodies--REVIEW]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_assertion evidence source_evidence_literature NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_assertion SIO_000772 18154448 NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_assertion wasDerivedFrom lhgdn-20090331 NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_assertion wasGeneratedBy ECO_0000203 NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.
- lhgdn-20090331 importedOn "2009-03-31" NP169221.RATZPFTRuBtB3wK_i9n385S2I03ndOGxWgMMxa9aUO-uM130_provenance.